Veterinary Research Forum

Abstract Ventricular septal defect (VSD) is a common congenital anomaly in large animals, but it is rarely documented in small ruminants. This report described a case involving a three-month-old male lamb of the Iranian Shall breed that was presented to a Veterinary Hospital of University of Tehran with nasal discharge and growth retardation. Clinical examination revealed a heart rate of 120 beats per min, a respiratory rate of 50 breaths per min, pale mucous membranes and a low-grade pansystolic murmur that was auscultated bilaterally in the thoracic region. Echocardio-graphy revealed a 10.00 mm defect between the right and left ventricles, located in the supraventricular region behind the aortic valve, along with evidence of left-to-right shunting. Imaging studies including echocardiography and radiography indicated increased cardiac volume particularly in the right ventricle. These findings were corroborated by necropsy. This case study aimed to elucidate the imaging findings associated with Ventricular septal defect in an Iranian Shall lamb.

Abstract The aim of this study was to introduce a new animal model of fecal incontinence (FI) by injecting abobotulinumtoxinA in the external anal sphincter (EAS) muscle of dogs which replaces models based on anal sphincter destructions that are invasive, mostly require surgical procedures, expensive, permanent, and painful to the animals. 4 healthy mongrel dogs were used in this study. First, they were received NaCl 0.09% (as control) injections in EAS muscle and effects were assessed by means of Electromyography (EMG) and clinically evaluated by sphincter pinch test and presence of leakage of feces for 2 weeks. Then, they received abobotulinumtoxinA in EAS muscle and reevaluated for 6 weeks to see short-term and medium-term effects of abobotulinumtoxinA injection. Saline had no significant changes in results obtained from EMG, however, there were significant decreases in amplitudes of action potentials after receiving abobotulinumtoxinA in comparison with no injection or saline injection in EAS muscle. Pinch tests were normal after saline injection assessment period, however, then started to be negative, ranging from two days after abobotulinumtoxinA injection to seven days after receiving abobotulinumtoxinA. Animals also had significant presentations of fecal incontinence (leakage of feces and cage contamination with feces) from the 1^st week after receiving abobotulinumtoxinA until the 6^th week after receiving abobotulinumtoxinA. AbobotulinumtoxinA caused paralysis in the EAS and producd FI conditions in dogs. This animal model was an appropriate substitute to the various invasive, expensive and also complicated procedures with an easy, feasible, noninvasive and non-painful single-stage abobotulinumtoxinA injection.